Application 062703

Type
ANDA
Sponsor
TEVA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEPHALEXINCEPHALEXINFOR SUSPENSION;ORALEQ 125MG BASE/5MLNoNo
002CEPHALEXINCEPHALEXINFOR SUSPENSION;ORALEQ 250MG BASE/5MLNoYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062703-001CEPHALEXINCEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13
A062703-002CEPHALEXINCEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A062703-001AB
A062703-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13caaa826d4ba7…
2026-08-18 06:07:402026-07A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13011fe1cb6892…
2026-02-19 14:30 UTC2026-02A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-136a471c1ec25d…
2025-08-23 18:47 UTC2025-08A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-132680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-135bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13d06236e962d9…
2024-10-29 15:01 UTC2024-10A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-131e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-138072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-138072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-135c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-135c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-135d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-135d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-134b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-134b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-1374a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-1374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062703-001CEPHALEXINEQ 125MG BASE/5MLFOR SUSPENSION / ORALAB1987-02-13bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062703-002CEPHALEXINEQ 250MG BASE/5MLFOR SUSPENSION / ORALABRS1987-02-13bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A062703-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A062703-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062703-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A062703-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062703-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062703-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A062703-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062703-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062703-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062703-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062703-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062703-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062703-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062703-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A062703-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062703-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062703-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062703-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062703-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062703-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062703-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062703-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062703-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062703-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062703-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062703-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062703-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062703-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062703-002AB1bb7c543d1eb4…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CephalexinCEPHALEXINNuCare Pharmaceuticals,Inc.549bf887-1ef6-6a75-e054-00144ff8d46c2024-08-14Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062703
application number: ANDA062703
ndc (product): 66267-982
CephalexinCEPHALEXINProficient Rx LPfebab51b-6b48-488a-8fd1-d24400e5df1d2022-07-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062703
application number: ANDA062703
ndc (product): 63187-205
CephalexinCEPHALEXINTeva Pharmaceuticals USA, Inc.19307ff0-71de-477b-965d-ea243e5ede3a2020-12-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062703
application number: ANDA062703
ndc (product): 0093-4175
ndc (product): 0093-4177

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 44 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-4175CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4175CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4175CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4175CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4175CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4175CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4177CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4177CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4177CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4177CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4177CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-4177CephalexinCephalexinTeva Pharmaceuticals USA, Inc.ANDACurrent
21695-551CephalexinCephalexinRebel Distributors CorpANDACurrent
21695-789CephalexinCephalexinRebel Distributors CorpANDACurrent
50090-0218CephalexinCephalexinA-S Medication SolutionsANDACurrent
50090-0219CephalexinCephalexinA-S Medication SolutionsANDACurrent
50090-0219CephalexinCephalexinA-S Medication SolutionsANDACurrent
50090-0220CephalexinCephalexinA-S Medication SolutionsANDACurrent
50090-0220CephalexinCephalexinA-S Medication SolutionsANDACurrent
50090-0220CephalexinCephalexinA-S Medication SolutionsANDACurrent
53002-2540CephalexinCephalexinRPK Pharmaceuticals, Inc.ANDACurrent
53002-2540CephalexinCephalexinRPK Pharmaceuticals, Inc.ANDACurrent
63187-205CephalexinCephalexinProficient Rx LPANDACurrent
63187-205CephalexinCephalexinProficient Rx LPANDACurrent
63187-205CephalexinCephalexinProficient Rx LPANDACurrent
66116-607CephalexinCephalexinMedVantx, Inc.ANDACurrent
66267-982CephalexinCephalexinNuCare Pharmaceuticals,Inc.ANDACurrent
66267-982CephalexinCephalexinNuCare Pharmaceuticals,Inc.ANDACurrent
68071-3186CephalexinCephalexinNuCarePharmaceuticals, Inc.ANDACurrent
68071-3186CephalexinCephalexinNuCarePharmaceuticals, Inc.ANDACurrent
68071-3186CephalexinCephalexinNuCarePharmaceuticals, Inc.ANDACurrent
68071-4177CephalexinCephalexinNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4587CephalexinCephalexinNuCare Pharmaceuticals,Inc.ANDACurrent
68788-9538CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9538CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9538CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9538CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9538CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9539CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9539CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9539CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9539CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
68788-9539CephalexinCephalexinPreferred Pharmaceuticals, Inc.ANDACurrent
70518-2077CephalexinCephalexinREMEDYREPACK INC.ANDACurrent